Rubfila International Ltd

Promoter to public reclassification

• Reclassification of Bharati B Dattani's 695,091 shares from promoter to public.
• Applications filed with NSE (15-09-2026) and BSE (16-09-2026) seeking no-objection.
• Disclosure is under Regulation 31A of SEBI LODR Regulations 2015.
• Status: no-objection yet; awaiting exchange confirmation.
• Potential effect: altered promoter/public shareholding composition.

Promoter to Public Reclassification

• Request received to reclassify 6,95,091 shares (1.28%) from Promoter to Public.
• Subject to Regulation 31A of SEBI LODR 2015.
• Date of request: 25-08-2026.
• Effect on promoter holding: 1.28% of paid-up capital.

AGM Details

• 33rd AGM held on 29 September 2026 at 11:00 AM via VC/OAVM.
• Quorum present; meeting conducted via VC/OAVM.
• Remote e-voting and AGM e-voting via CDSL; participation through VC/OAVM.
• Accounts for year ended 31 March 2026 and AGM notice taken as read.

Rubfila International Ltd – Closure of Trading Window

Dividend record date

• Purpose: Final dividend of Rs 2 per equity share for FY 2025-26.
• Security: Equity shares (face value Rs 5) of Rubfila International Ltd.
• Record date: 22-09-2026 for dividend entitlement.
• Dividend declared by board at its meeting on 26-05-2026.
• Payment timeline: not specified.

Promoter-to-Public reclassification

• Board approves initiating reclassification of Bharati Dattani from Promoter to Public under Regulation 31A.
• Subject to applicable regulatory requirements and stock exchange no-objection approvals.
• To file no-objection applications with BSE and NSE for the proposed reclassification.
• To place the reclassification request before shareholders for approval.
• Authorized MD, Company Secretary, and/or officers to file disclosures and representations before authorities.

PTIL divestment details

• Board approved sale of Rubfila's entire stake in Premier Tissues India Limited.
• Aggregate consideration fixed at €61.00 crore.
• Proposed purchaser is Finquest Personal Care Pvt. Ltd.
• Payment to be made within 30 days after shareholder or regulatory approvals.
• Transaction on an as-is, no further due diligence.
• Subject to requisite shareholder and other statutory/regulatory approvals.
• Hardik Patel recused from deliberations due to related-party status.
• Valuation reports from two independent valuers considered.
• PTIL will cease to be Rubfila's subsidiary on completion.
• Execution of transaction documents and disclosures to exchanges to be completed.
• Board authorized officers to undertake actions and disclosures.

PTIL financials & execution timeline

• PTIL turnover for year ended 31-03-2026: ₹95.74 crore.
• PTIL net worth as of 31-03-2026: ₹51.49 crore.
• PTIL contributed 15.68% of Rubfila's consolidated revenue.
• Execution documents expected by 10-09-2026.

Governance & approvals

• Shareholder approvals and other statutory/regulatory approvals required.
• 33rd AGM scheduled for 29 September 2026 at 11:00 AM.
• Board authorized Company Secretary to complete disclosures and filings.

Regulatory & completion timeline

• Divestment subject to Companies Act 2013 and SEBI LODR compliance.
• Transaction completion within 30 days of approvals.